...
首页> 外文期刊>Indian journal of pharmaceutical sciences. >Formulation and in vitro evaluation of alfuzosin extended release tablets using directly compressible eudragit
【24h】

Formulation and in vitro evaluation of alfuzosin extended release tablets using directly compressible eudragit

机译:使用直接可压缩的eudragit制剂和阿夫唑嗪缓释片的体外评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the present study was the determination of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressible Eudragit (RS PO) was used in tablets prepared by direct compression. The amounts of both polymers were taken as independent variables for the 3 2 Factorial design. The percent drug releases at 1, 6, 12 and 20 h were selected as responses. The main effect and interaction terms were quantitatively evaluated using mathematical model. Dissolution data were fitted to zero order, first order, and Higuchi′s release kinetics to evaluate kinetic data. Both the diffusion and erosion mechanisms were responsible for drug release as shown by the power law. The release of Alfuzosin was prolonged for 20 h by binary mixer indicating the usefulness of the formulations for once daily dosage forms.
机译:本研究的目的是确定制剂因子并体外评估易溶的弱碱性药物(盐酸阿夫唑嗪)的延长释放剂型。一种亲水性聚合物(羟丙基甲基纤维素)和一种直接可压缩的Eudragit(RS PO)的二元混合器用于通过直接压缩制得的片剂中。两种聚合物的量均作为3 2因子设计的自变量。选择1、6、12和20小时的药物释放百分比作为响应。使用数学模型定量评估了主要作用和相互作用项。将溶出度数据拟合为零阶,一阶和Higuchi的释放动力学,以评估动力学数据。如幂定律所示,扩散和腐蚀机制均与药物释放有关。通过二元混合器将阿夫唑嗪的释放延长20小时,这表明该制剂对于每日一次剂型的有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号